Last update 21 Nov 2024
CD70 CAR-T cell therapy (Yake Biotechnology)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type CAR-T |
Synonyms |
Target |
Mechanism CD70 inhibitors(CD70 antigen inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with CD70 CAR-T cell therapy (Yake Biotechnology)A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Refractory or Relapsed Solid Tumors
Clinical Trial for the Safety and Efficacy of CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases
100 Clinical Results associated with CD70 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
100 Translational Medicine associated with CD70 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
100 Patents (Medical) associated with CD70 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
100 Deals associated with CD70 CAR-T cell therapy (Yake Biotechnology)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | - | 22 Apr 2024 | |
| CD70 positive Neoplasms | Phase 1 | - | 22 Apr 2024 | |
| Nasopharyngeal Carcinoma | Phase 1 | - | 22 Apr 2024 | |
| Neoplasm Metastasis | Phase 1 | - | 22 Apr 2024 | |
| Ovarian Cancer | Phase 1 | - | 22 Apr 2024 | |
| Renal Cell Carcinoma | Phase 1 | - | 22 Apr 2024 | |
| Squamous Cell Carcinoma of Head and Neck | Phase 1 | - | 22 Apr 2024 | |
| Uterine Cervical Cancer | Phase 1 | - | 22 Apr 2024 | |
| Multiple Myeloma | Phase 1 | CN | 18 Nov 2021 | |
| Multiple Myeloma | Phase 1 | CN | 18 Nov 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free